×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win
Reuters
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed...
1 day ago
Pfizer, Astellas' Xtandi combo extends survival in early prostate cancer setting
FirstWord Pharma
Pfizer and Astellas announced Thursday that in the Phase III EMBARK study, the combination of Xtandi (enzalutamide) and leuprolide...
1 day ago
Sally Susman waves goodbye to Pfizer; Xaira’s new president and COO
Endpoints News
Sally Susman to depart Pfizer as corporate affairs head after 18 years, leaving end of 2025. Helped shape company image, especially during...
14 hours ago
AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer
Fierce Biotech
AbbVie is paying Ichnos Glenmark Innovation (IGI) $700 million upfront for a next-generation rival to Johnson & Johnson's Tecvayli,...
1 day ago
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
Yahoo Finance
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a...
9 hours ago
EU President fends off no-confidence vote over Pfizer texts
pharmaphorum
EU President Ursula von der Leyen has survived a no-confidence vote in the European Parliament over text messages she sent to Pfizer's CEO.
1 day ago
Pfizer’s EPIC-Peds Study: New Insights into Pediatric COVID-19 Treatment
TipRanks
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled 'EPIC-Peds' to...
9 hours ago
Why Pfizer’s Josh Palau Can’t Wait To Buy Netflix Through The Yahoo DSP
AdExchanger
The expansion of Netflix's programmatic offerings couldn't come at a better time for Pfizer.
20 hours ago
Pfizer’s Reputation Chief Leaving as Company Shuffles Executives
Bloomberg
Sally Susman, who has presided over Pfizer Inc.'s public communications for nearly two decades, will leave the company this year as part of...
3 days ago
Pfizer Earnings Preview: What To Expect
Barchart.com
Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company's bottom-line...
2 days ago